DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Oyajobi BO, Garrett IR, Gupta A. et al.
Stimulation of new bone formation by the proteasome inhibitor, bortezomib: implications for myeloma bone disease.
Br J Haematol 2007; 139 (3): 434-438
We do not assume any responsibility for the contents of the web pages of other providers.